Paper
RSC Advances
Trans. 1, 1990, 1665; (d) A. de Fatima, L. V. Modolo,
L. S. Conegero, R. A. Pili, C. V. Ferreira, L. K. Kohn and
J. E. de Carvalho, Curr. Med. Chem., 2006, 13, 3371.
10 Q. Mu, W. Tang, C. Li, Y. Lu, H. Sun, H. Zheng, X. Hao,
Q. Zheng, N. Wu, L. Lou and B. Xu, Heterocycles, 1999, 51,
2969.
11 Z. Tian, S. Chen, Y. Zhang, M. Huang, L. Shi, F. Huang,
C. Fong, M. Yang and P. Xiaol, Phytomedicine, 2006, 13, 181.
12 (a) M. G. Banwell, M. J. Coster, O. P. Karunaratne and
J. A. Smith, J. Chem. Soc., Perkin Trans. 1, 2002, 1622; (b)
M. Mondon and J.-P. Gesson, Curr. Org. Synth., 2006, 3, 41;
(c) G. Zhao, B. Wu, X. Wu and Y. Z. Zhang, Mini-Rev. Org.
Chem., 2005, 2, 333; (d) K. R. Prasad and M. G. Dhaware,
Synlett, 2007, 1112.
Acknowledgements
H. S. K. and T. D. thank CSIR, New Delhi, India, for the award of
a research fellowship. S. P. C. thanks CSIR, New Delhi, India, for
nancial support as part of XIIth Five Year plan programme
under the titles ACT (CSC-0301) and ORIGIN (CSC-0108). T. D.
and K. V. acknowledge the Centre of Excellence in Scientic
Computing, NCL, Pune for providing computational resources
and also acknowledge the Multi-Scale simulation and Modeling
project (MSM) for nancial assistance. The authors thank Dr U.
R. Kalkote and Dr H. B. Borate for helpful discussions.
Notes and references
1 E. P. Kohler and D. Thompson, J. Am. Chem. Soc., 1933, 55,
3822, and the references cited therein.
13 (a) J. P. Surivet and J. M. Vatele, Tetrahedron, 1999, 55, 13011;
(b) M. Tsukubi, K. Kanai, H. Nagase and T. Honda,
Tetrahedron, 1999, 55, 2493; (c) E. W. Tate, D. J. Dixon and
S. V. Ley, Org. Biomol. Chem., 2006, 4, 1698; (d) J. S. Yadav,
S. Das and A. K. Mishra, Tetrahedron: Asymmetry, 2010, 21,
2443; (e) I. N. C. Kiran, R. S. Reddy, G. Suryavanshi and
A. Sudalai, Tetrahedron Lett., 2011, 52, 438.
14 (a) P. V. Ramachandran, J. S. Chandra and M. V. R. Reddy, J.
Org. Chem., 2002, 67, 7547; (b) T. Yoshida, S. Yamauchi,
R. Tago, M. Maruyama, K. Akyiama, T. Sugahara,
T. Kishida and Y. Koba, Biosci., Biotechnol., Biochem., 2008,
72, 2342; (c) G. Sabitha, K. Sudhakar and J. S. Yadav,
Synthesis, 2007, 385; (d) V. Bacchu and G. V. M. Sharma,
Synlett, 2014, 25, 1283; (e) G. Kumaraswamy and R. Satish
Kumar, Helv. Chim. Acta, 2013, 96, 1366; (f) K. R. Prasad
and S. L. Gholap, Tetrahedron Lett., 2007, 48, 4679.
15 The ee was determined from HPLC analysis, provided in the
ESI.†
16 (a) K. Mikami, N. Md. Islam, M. Yamanaka, Y. Itoh,
M. Shinoda and K. Kudo, Tetrahedron Lett., 2004, 45, 3681;
(b) L. Zhou, X. Liu, J. Ji, Y. Zhang, W. Wu, Y. Liu, L. Lin
and X. Feng, Org. Lett., 2014, 16, 3938; (c) B. Zhang,
L. Han, T. Li, J. Yan and Z. Yang, Synth. Commun., 2014,
44, 1608; (d) T. Li, C. Xiang, B. Zhang and J. Yan, Helv.
Chim. Acta, 2014, 97, 854; (e) V. Valerio, D. Petkova,
C. Madelaine and N. Maulide, Chem.–Eur. J., 2013, 19, 2606.
17 As an application of this methodology, the enantioselective
synthesis of venlafaxine is actively in progress and it will
be reported in due course.
2 (a) F. C. Whitmore, J. S. Whitakar, W. A. Mosher,
O. N. Brevik, W. R. Wheeler, C. S. Miner Jr,
L. H. Sutherland, R. B. Wagner, T. W. Clapper, C. E. Lewis,
A. R. Lux and A. H. Popkin, J. Am. Chem. Soc., 1941, 63,
643; (b) F. C. Whitmore and R. S. George, J. Am. Chem. Soc.,
1942, 64, 1239 and the references cited therein.
3 C. D. Nenitzesku and I. Necsoin, J. Am. Chem. Soc., 1950, 72,
3483.
4 (a) P. Canonne, G. B. Foscolos and D. Belanger, J. Org. Chem.,
1980, 45, 1828; (b) P. Canonne, D. Belanger, G. Lemay and
G. B. Foscolos, J. Org. Chem., 1981, 46, 3091; (c)
P. Canonne, G. Fytas and D. Thibeauit, Tetrahedron Lett.,
1983, 24, 2991; (d) P. Canonne, H. Caron and
G. B. Foscolos, Tetrahedron, 1984, 40, 865.
5 M. Ferles, M. Lebb, A. Silhankova, P. Stem and Z. Wimmer
Coil, Collect. Czech. Chem. Commun., 1975, 40, 1571.
6 P. Canonne, D. Belanger and G. Lemay, Tetrahedron Lett.,
1981, 22, 4995.
7 S. P. Chavan, D. A. Khobragade, M. Thakkar and
U. R. Kalkote, Synth. Commun., 2007, 37, 3901.
8 (a) T. W. Sam, C. Saw-Yeu, S. Matsjeh, E. K. Gan, D. Razak
and A. L. Mohamed, Tetrahedron Lett., 1987, 28, 2541; (b)
Y. C. Wu, C. Y. Duh, F. R. Chang, S. K. Wang, J. J. Chang,
D. R. McPhail, A. T. McPhail and K. H. Lee, J. Nat. Prod.,
1991, 54, 1077; (c) S. K. Talapatra, D. Basu, T. Deb,
S. Goswami and B. Talapatra, Indian J. Chem., Sect. B: Org.
Chem. Incl. Med. Chem., 1985, 24, 29; (d) X. P. Fang,
J. E. Anderson, C. J. Chang and J. L. McLaughlin, J. Nat.
Prod., 1991, 54, 1034.
18 For further details of the computational method, please see
the ESI le.†
9 (a) H. B. Mereyala and M. Joe, Curr. Med. Chem.: Anti-Cancer
19 (a) S. Yamazaki and S. Yamabe, J. Org. Chem., 2002, 67, 9346–
9353; (b) P. Merino and T. Tejero, Tetrahedron, 2001, 57,
8125–8128.
´
Agents, 2001, 1, 293; (b) M. A. Blazquez, A. Bermejo,
M. C. Zafra-Polo and D. Cortes, Phytochem. Anal., 1999, 10,
161; (c) X. P. Fang, J. E. Anderson, C. J. Chang,
P. E. Fanwick and J. L. McLaughlin, J. Chem. Soc., Perkin
This journal is © The Royal Society of Chemistry 2016
RSC Adv., 2016, 6, 50721–50725 | 50725